Evidence map›Paper›PMID 29867807›Full record

ArticleFrontiers in microbiology2018

The Growth and Protein Expression of Inflammatory Bowel Disease-Associated

Rena Ma, Fang Liu, Soe F Yap, Hoyul Lee, Rupert W Leong, Stephen M Riordan, Michael C Grimm, Li Zhang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pathogenomics of EmergingClinical microbiology reviews · 2019
    Review
  5. The Clinical Importance ofFrontiers in cellular and infection microbiology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Rena MaThe School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.
Fang LiuThe School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.
Soe F YapThe School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.
Hoyul LeeThe School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.
Rupert W LeongConcord Hospital, University of New South Wales, Sydney, NSW, Australia.
Stephen M RiordanGastrointestinal and Liver Unit, The Prince of Wales Hospital, Sydney, NSW, Australia.
Michael C GrimmSt George and Sutherland Clinical School, University of New South Wales, Sydney, NSW, Australia.
Li ZhangThe School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.
UNSW Sydney · AUPrince of Wales Hospital · AUSutherland Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory bowel diseases (IBD) are chronic inflammatory conditions of the gastrointestinal tract with multifactorial etiology. Both dietary factors and the microbe

Indexed as

Campylobacter concisusenteric bacteriafood additivesinflammatory bowel diseasesodium fumarate

Identifiers

PMID29867807
PMCPMC5966568
OpenAlexW2802472959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.